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Background—Fractional flow reserve predicts cardiac events after coronary stent implantation. The aim of the present
study was to assess the 9-month angiographic in-stent restenosis rate in the setting of optimal stenting and a persisting
gradient distal to the stent as assessed by a pressure wire pullback recording in the entire length of the artery.
Methods and Results—In 98 patients with angina pectoris, 1 de novo coronary lesion was treated with a bare-metal stent.
After stent implantation, pressure wire measurements (Pdmean hyperemic coronary pressure and Pamean aortic
pressure) were performed in the target vessel: (1) Pd/Pa as distal to the artery as possible (fractional flow reserve per
definition); (2) Pd/Pa just distal to the stent; (3) Pd/Pa just proximal to the stent; and (4) Pd/Pa at the ostium. Residual
abnormal Pd/Pa was defined as a pressure drop between Pd/Pa measured at points 1 and 2. Fractional flow reserve distal
to the artery after stenting was significantly lower (0.880.21 versus 0.970.05; P0.001), and angiographic in-stent
binary restenosis rate was significantly higher (44.0% versus 8.1%; P0.001) in vessels with a residual abnormal Pd/Pa.
Residual abnormal Pd/Pa (odds ratio, 4.39; 95% confidence interval, 1.10 to 18.16; P0.034), reference vessel size (odds
ratio, 0.17; 95% confidence interval, 0.04 to 0.69; P0.013), and stent length (odds ratio, 1.11; 95% confidence interval,
1.03 to 1.21; P0.009) were predictors of angiographic in-stent restenosis after 9 months.
Conclusions—A residual abnormal Pd/Pa distal to a bare-metal stent was an independent predictor of in-stent restenosis
after implantation of a coronary bare-metal stent. (Circulation. 2007;116:2802-2808.)
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Until recently, restenosis was a major problem in percu-taneous coronary intervention (PCI). The introduction
of coronary stents reduced the rate of restenosis,1–4 but
in-stent restenosis still appears in a number of patients. Studies
using intravascular ultrasound and pathological studies have
shown that angiographic stenoses are associated with diffuse
atherosclerosis in the distal part of the coronary tree, although
this may not be identified by coronary arteriography.5
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Coronary pressure measurement with determination of
fractional flow reserve (FFR)6,7 has been proposed as a
supplementary technique for optimizing PCI results.8–10 In
addition, FFR has been shown to have a predictive value after
PCI.11,12 FFR measured after stenting with the pressure wire
located distal to the stent indicates the effects on maximal
flow of the stented segment and of the remaining part of the
artery. A complete analysis of the coronary artery after PCI
can be achieved by a pressure wire pullback during sustained
hyperemia induced by intravenous adenosine. A pullback
pressure recording in an epicardial coronary artery reflects
the conductance of the entire artery as well as of the
individual segments. In diffusely diseased coronary arteries, a
marked pressure drop may occur between an implanted stent
and the distal part of the artery.
The aim of the present study was to assess the in-stent
restenosis rate in the setting of optimal stent implantation and
a persisting pressure gradient in the vessel distal to the stent
as assessed by a pressure wire pullback recording in the
stented coronary artery.
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From October 2002 to December 2004, 98 patients with a single
lesion in a native coronary artery and planned PCI were enrolled at
Odense University Hospital, Aarhus University Hospital, Skejby
Sygehus, or Rigshospitalet, Copenhagen, Denmark. Patients with a
total occluded artery or acute myocardial infarction were excluded.
All patients were on aspirin (75 mg/d) and clopidogrel (loading dose
300 mg 24 hours before PCI, continued on 75 mg/d for 12 months).
A total of 88 patients (90%) had a 9-month angiographic follow-up.
The study population was divided into 2 groups: group I, patients
with a pressure gradient in the nonstented part of the vessel distal to
the stent; and group II, patients without a pressure gradient distal to
the stent. Stent names are shown in the online-only Data Supplement.
The patients provided written, informed consent, and the local
institutional review board (Scientific Ethics Committee for the
counties of Vejle and Funen, Denmark) approved the protocol (case
No. 20020045).
Intracoronary Pressure Measurements
Before pressure measurements and intervention, the patients had a
200-g intracoronary nitroglycerin and a 5000- to 10 000-U intra-
venous heparin administration. A 0.014-inch pressure wire (Pres-
sureWire, Radi Medical Systems, Uppsala, Sweden, or WaweWire,
JoMed, Helsinborg, Sweden) was passed through the target lesion
and placed as distal to the coronary artery as possible. Maximal
hyperemia was induced by intravenous adenosine (140 g/kg per
min), and the ratio Pd/Pa was calculated. Here, Pd represents mean
hyperemic coronary pressure of the index vessel measured by the
pressure wire, and Pa represents mean aortic pressure measured by
the guiding catheter. After stenting, a slow manual pullback of the
pressure sensor from the most distal position to the proximal part of
the artery was performed at maximal hyperemia and recorded on
paper. Pressure measurements were performed in the whole length of
the artery: Pd/Pa was measured as (1) distal in the artery as possible
(per definition of FFR), (2) just distal to the stent, (3) just proximal
to the stent, and (4) and at the ostium (Figure 1). A residual abnormal
Pd/Pa was defined as a pressure drop between hyperemic Pd/Pa
measured at points 1 and 2. On the basis of the pressure measure-
ments, 2 groups of patients were defined. In group I, hyperemic Pd/Pa
point 1-hyperemic Pd/Pa point 2 was 0, and in group II, hyperemic
Pd/Pa point 1hyperemic Pd/Pa point 2.
Quantitative Coronary Angiography
Angiographic studies performed at baseline, after the procedure, and
at follow-up were assessed at the Angiographic Core Laboratory
(Catheterization Laboratory, Odense University Hospital, Odense,
Denmark). The computer-based ACOM.PC V3.1 (Siemens Medical
Systems, Inc) was used for quantitative coronary angiography.
Quantitative analysis was performed offline by experienced person-
nel unaware of the pressure measurements. The same 2 projections
were used at all time points. The following angiographic measure-
ments were measured: reference diameter of the vessel, minimal
luminal diameter, percent diameter stenosis [1(minimal luminal
diameter/reference segment diameter)100], and late lumen loss
(difference between minimal luminal diameter at the end of the
procedure and at follow-up).
Study End Point and Definitions
The primary end point of the study was binary angiographic
restenosis 50% after 9 months. Optimal stenting was based on
visual estimates by the operator and defined as a residual stenosis of
0. The core laboratory qualitative comparative analysis could over-
rule the visual operator assessment.
Statistical Analysis
Statistical analysis was performed with the use of SPSS 14.0.
Categorical data were presented as counts and percentages and
compared by the Pearson 2 test or the Fisher exact test. Continuous
data were expressed as meanSD and compared by t test. Two-way
ANOVA with 4 repeated measurements was used to test whether a
significant change occurred in measurements at different wire
positions. If this test was significant, a paired t test was used to
compare the values between the relevant wire positions. Separate
logistic regression analyses were performed to identify univariate
predictors of binary angiographic restenosis, and a subsequent
stepwise (forward conditional) regression analysis was performed
with entry and removal criteria of 0.05 and 0.10, respectively.
Logistic regression analyses were presented as odds ratio (OR) with
95% confidence intervals. All statistical tests were 2-tailed.
With anticipation of a mean binary angiographic restenosis
(50%) rate of 25% after 9 months, the 166 patients enrolled
provided 80% power and a 5%  level to detect a difference of 20%
(event rate of 15% and 35%, respectively). A probability value
0.05 (2-sided) was considered statistically significant.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
Baseline Characteristics and Procedural Results
The clinical features at baseline are shown in Table 1. Age
and risk factors did not differ significantly between the 2
groups: group I with abnormal residual Pd/Pa (n58) and
group II without abnormal residual Pd/Pa (n40).
Lesion Characteristics
The occurrence of 1- and 2-vessel coronary artery disease was
similar in the 2 groups. Diameter stenosis and lesion type did
not differ between the 2 groups. Lesions tended to be longer
in patients with residual abnormal Pd/Pa (Table 2). Patients
with residual abnormal Pd/Pa had more left anterior descend-
ing artery lesions and fewer left circumflex artery lesions
treated. The reference diameter was significantly lower in
patients with residual abnormal Pd/Pa compared with patients
without residual abnormal Pd/Pa (2.90.6 versus 3.30.5;
P0.001).
Figure 1. Illustration of different measurement points. FFR indi-
cates FFR measured distal in the vessel; Pd/Padist, Pd/Pa just
distal to the stent; Pd/Paprox, Pd/Pa just proximal to the stent;
and Pd/Paostium, Pd/Pa at the ostium.
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FFR and Pd/Pa at Different Pressure
Wire Positions
Preinterventional FFR was significantly lower in vessels with
residual abnormal Pd/Pa compared with vessels without resid-
ual abnormal Pd/Pa (Table 2). FFR before intervention corre-
lated inversely with the angiographic diameter stenosis
(r0.562, P0.001) (Figure 2). FFR increased signifi-
cantly after PCI (0.950.09 versus 0.650.20; P0.001).
No artery showed a sudden increase in distal coronary
pressure by pressure wire pullback. This indicated that the
pressure gradient, observed in the distal part of the artery, was
due to a continuous loss of pressure in the artery distal to the
stented segment and was not caused by an angiographically
undetected focal narrowing. After the intervention, a signif-
icant within-subject change of Pd/Pa occurred in the entire
artery in patients with a residual abnormal Pd/Pa (group I)
(P0.001, 2-way ANOVA analysis; Figure 3), whereas the
within-subject change of Pd/Pa did not differ significantly
along the entire length of the artery in patients without a
residual abnormal Pd/Pa (group II). In group I, FFR
(pressure wire placed in the distal vessel) was significantly
lower than hyperemic Pd/Pa just distal to the stent
(0.880.12 versus 0.940.11; P0.001). In both groups,
a small trans-stent gradient was present (Pd/Pa just distal to
the stent versus Pd/Pa just proximal to the stent) (group I,
0.940.10 versus 0.970.08, P0.001; group II,
0.970.05 versus 0.990.04, P0.001). In group I,
29.3% (n17) of the lesions had no trans-stent pressure
gradient, and in group II, 67.5% (n27) of the lesions had
no trans-stent pressure gradient (P0.001).
Table 1. Baseline Characteristics
Group I (Residual
Abnormal Pd/Pa Ratio)
Group II (No Residual
Abnormal Pd/Pa Ratio) P
No. of patients 58 40
Men, % 84.5 84.6 NS
Age, meanSD, y 61.910.2 62.48.1 NS
Current smoker, % 27.6 20.5 NS
Hypertension, % 36.2 35.9 NS
Hypercholesterolemia, % 82.8 92.3 NS
Diabetes mellitus, % 8.5 19.0 NS
Body mass index, meanSD, kg/m2 26.34.0 27.94.0 NS
Prior myocardial infarction, % 43.1 35.9 NS
Prior PCI, % 6.9 7.7 NS
Stable angina pectoris, % 89.7 92.3 NS
1-vessel disease 67.8 69.0 NS
2-vessel disease 27.1 28.6 NS
3-vessel disease 5.1 2.4 NS
Medication
Antianginal medication 2 drugs, % 21.1 33.3 NS
Aspirin, % 100 100 NS
Clopidogrel, % 100 100 NS
Statin, % 88.1 89.3 NS
NS indicates not significant.
Table 2. Lesion and Procedure Characteristics
Group I (Residual
Abnormal Pd/Pa Ratio)
Group II (No Residual
Abnormal Pd/Pa Ratio) P
No. of patients, % 58 40
LAD/CX/RCA, % 30/40/30 57/10/33 0.004
Reference diameter, mm 2.860.56 3.270.53 0.001
Diameter stenosis, % 66.413.9 69.514.3 NS
Lesion type (A/B/C), % 21/68/11 33/59/8 NS
Lesion length, mm 14.88.6 12.24.9 0.072
Stent length, mm 18.28.9 16.06.5 NS
Direct stenting, % 40.0 35.1 NS
FFR before intervention 0.620.21 0.710.19 0.033
FFR after intervention 0.880.12 0.970.05 0.001
Values are expressed as meanSD unless otherwise indicated. LAD indicates left anterior
descending artery; CX, circumflex artery; and RCA, right coronary artery.
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FFR After PCI in the Individual Vessels With and
Without a Residual Abnormal Pd/Pa Ratio Distal
to the Stent
No significant differences in Pd/Pa were present just distal to
the stent for the 3 major coronary arteries in group I (left
anterior descending artery, 0.900.13; left circumflex artery,
0.980.08; right coronary artery, 0.940.07; PNS) or
group II (left anterior descending artery, 0.940.04; left
circumflex artery, 0.980.06; right coronary artery,
0.970.04; PNS). FFR after PCI was significantly lower in
vessels with a residual abnormal Pd/Pa ratio compared with
vessels without a residual abnormal Pd/Pa ratio (0.880.21
versus 0.970.05; P0.001).
Angiographic Follow-Up and Event Rate
At 9-month follow-up, in-stent binary angiographic restenosis
was demonstrated in 28.6% of patients with angiographic
follow-up (Table 3) (25.7% of all patients). Target lesion
revascularization was performed in 24.2% of patients with
angiographic follow-up (21.8% of all patients). The in-stent
binary angiographic restenosis rate was 21.1% (n8) for
right coronary artery lesions, 30.4% (n7) for left anterior
descending artery lesions, and 37.5% (n9) for left circum-
flex artery lesions. In vessels with a residual abnormal Pd/Pa
ratio, binary angiographic restenosis was seen in 44.0%
compared with 8.1% in vessels without a residual abnormal
Pd/Pa ratio (P0.001). During the 9-month follow-up, no
stent thrombosis was seen, and none of the patients died or
suffered an acute myocardial infarction.
Predictors of In-Stent Binary
Angiographic Restenosis
Logistic regression analysis was used to assess independent
predictors of binary angiographic restenosis at 9 months. The
parameters examined with the use of univariate logistic
regression analysis are shown in Table 4. A residual abnormal
Pd/Pa, reference vessel diameter, minimal luminal diameter
after stent implantation, lesion length, and stent length were
significantly associated with an increased rate of binary
angiographic restenosis. To adjust for differences in lesion
factors, we performed a multiple logistic regression analysis
including the abnormal residual Pd/Pa ratio (as the variable of
primary interest) and reference vessel diameter (as a well-
known factor influencing binary angiographic restenosis) by
forced entry and parameters with P0.20 (from the univari-
ate analysis) in a forward stepwise procedure. Included in the
forward procedure were minimal luminal diameter after stent
implantation, lesion length, stent length, FFR before PCI, and
FFR after PCI. After these adjustments, a residual abnormal
Pd/Pa ratio, reference vessel diameter, and stent length were
found to be predictors of binary angiographic restenosis at 9
months (Table 5). Performing a backward stepwise procedure
showed the same predictors of binary angiographic resteno-
sis. The c statistic (area under the receiver operating charac-
teristic curve) in the final model was 0.83.
Number of Patients Included
According to the power calculation, 166 patients were ex-
pected to be included. However, during the enrollment period
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Figure 2. FFR vs angiographic diameter stenosis. FFR corre-
lates inversely to the angiographic diameter stenosis.
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A residual abnormal Pd/Pa ratio distal to the stent
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No residual abnormal Pd/Pa ratio distal to the stent
Figure 3. Mean values (and 95% confidence interval for the
mean) of FFR distal in the vessel, hyperemic Pd/Pa just distal to
the stent, hyperemic Pd/Pa just proximal to the stent, and hyper-
emic Pd/Pa at the ostium evaluated with a complete analysis of
the stented coronary artery with a pullback pressure recording.
Top, Patients with a residual abnormal Pd/Pa ratio (group I). Bot-
tom, Patients without a residual abnormal Pd/Pa ratio (group II).
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the drug-eluting stents were implemented for clinical use, and
the study was stopped before enrollment of the 166 patients in
order not to have a selected cohort with bare-metal stents.
In regard to calculating the power with the observed differ-
ence of 44.0%8.1%35.9% in the event rate with binary
angiographic restenosis, for a comparison of 2 independent
binomial proportions with the use of the likelihood ratio statistic
with a 2 approximation with a 2-sided significance level of
0.05, group sample sizes of 50 and 38 have an approximate
power of 0.974 when the proportions are 0.44 and 0.081.
Discussion
The present study demonstrated that pressure reduction from an
implanted stent to the distal part of the artery was a predictor of
angiographic in-stent restenosis after 9 months. The pressure
reduction was detected by a systematic analysis of the entire
length of the stented coronary artery with a pullback pressure
wire recording. A sudden increase in distal coronary pressure
was not seen in any of the investigated arteries during the
pullback procedure. Therefore, the pressure gradient observed in
the distal part of the artery was due to a continuous loss of
pressure in the artery distal to the stented segment and not to an
angiographically undetected focal narrowing. A residual abnor-
mal Pd/Pa ratio suggests diffuse disease in the remaining part of
the artery, but diffuse disease was not documented by either
angiography or intravascular ultrasound imaging.
In normal coronary arteries, no gradient exists between the
ostium and the distal part of the artery despite induced
hyperemia. In patients with angiographically mild disease,
Gould et al13 demonstrated a base-to-apex myocardial perfu-




Group II (No Residual
Abnormal Pd/Pa Ratio) P
No. of patients 58 40   
No. of patients with angiographic
follow-up
50 38   
Before intervention
Reference diameter, mm 2.860.56 3.270.53 0.001
Minimal lumen diameter, mm 0.410.06 0.470.08 NS
Diameter stenosis, % 66.413.9 69.514.1 NS
After PCI
Reference diameter, mm 2.860.62 3.200.57 0.011
Minimal lumen diameter, mm 2.590.51 2.940.56 0.003
Diameter stenosis, % 8.111.0 7.611.8 NS
Follow-up
No. of patients, n (%) 51 (84.7) 40 (90.5)   
Reference diameter, mm 2.710.59 3.010.63 0.027
Minimal lumen diameter, mm 1.510.78 2.230.68 0.001
Late lumen loss, mm 1.090.72 0.710.59 0.011




Data are expressed as meanSD unless otherwise indicated. NS indicates not significant.
Table 4. Predictors for Binary Angiographic Restenosis
(Univariate Analysis)
Variable OR 95% CI P
Age 1.03 0.97–1.09 NS
Diabetes mellitus 5.18 0.63–42.43 0.126
Smoking 1.33 0.46–3.84 NS
Study vessel* 0.83 0.26–2.70 NS
FFR before PCI 0.08 0.01–0.92 0.043
FFR after PCI 0.01 0.00–1.16 0.058
Residual abnormal Pd/Pa
ratio distal to the stent
9.16 2.49–33.79 0.001
Lesion length 1.09 1.02–1.17 0.011








CI indicates confidence interval; NS, not significant.
*Circumflex as reference.
Table 5. Predictors for Binary Angiographic Restenosis
(Multivariable Analysis)
Variable OR 95% CI P
Residual abnormal Pd/Pa ratio
distal to stent
4.58 1.11–18.84 0.034
Reference vessel diameter 0.17 0.04–0.71 0.014
Stent length 1.11 1.03–1.21 0.010
Predictors initially included in the model were as follows: residual abnormal
Pd/Pa ratio distal to the stent, reference vessel diameter, minimum lumen
diameter, lesion length, stent length, FFR before PCI, FFR after PCI distal to
artery, and diabetes mellitus. CI indicates confidence interval.
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sion gradient after dipyridamole administration by positron
emission tomography without significant regional perfusion
defects. It has been shown by coronary pressure measure-
ments that a base-to-apex perfusion gradient can be due to
abnormal resistance in atherosclerotic epicardial coronary
arteries without segmental stenosis5 because diffuse coronary
atherosclerosis with no focal stenoses results in a graded,
continuous pressure drop in the artery. This is in accordance
with the findings of the present study, in which optimal
coronary stenting resulted in a minimum hyperemic pressure
drop within the stented coronary artery segment, whereas the
transstenotic hyperemic gradient was not eliminated fully
after stenting when the entire artery was evaluated. The
minimum hyperemic pressure drop across the stented seg-
ment might indicate a small resistance to blood flow, but the
present study was not designed to obtain a total elimination of
the transstenotic hyperemic gradient after stenting.
After treatment with bare-metal stents, several studies have
demonstrated that FFR predicts major cardiac events.11,12
However, when FFR is reduced after stenting, it is important
to distinguish between a persistent hyperemic gradient due to
incomplete deployment and a gradient caused by diffuse
disease proximal or distal to the treated lesion. Consequently,
evaluation of stent deployment by FFR can be improved by
calculations of Pd/Pa distal and proximal to the stent during
maximal hyperemia to assess the conductance of the stented
segment. In the present study, FFR distal to the artery tended
to be related to development of in-stent restenosis.
Reference Vessel Size
The second independent predictor of angiographic in-stent
restenosis after 9 months was reference vessel size. The
ability to distinguish between large and small coronary
arteries on the basis of quantitative coronary angiography is
essential in PCI, and stent implantation in small arteries is a
well-known independent risk factor of restenosis and major
adverse cardiac events after PCI.14–16 The mechanisms be-
hind the unfavorable outcome for small vessels are not well
understood. In addition to a small postprocedural lumen
diameter, a high plaque burden and pronounced diffuse
disease may be important factors.17 Pathological and intra-
vascular ultrasound studies have shown that an angiographi-
cally documented stenosis is associated with diffusely ath-
erosclerotic changes in other parts of the coronary artery,
although this may not be identified by coronary arteriogra-
phy.18–20 These findings are in accordance with the present
study, in which coronary arteries without diffuse disease had
a larger reference vessel diameter.
Pressure Pullback Recordings With
Intravenous Adenosine
In the present study, maximum hyperemia was achieved with
continuous intravenous adenosine infusion because intracoro-
nary adenosine was too short-acting for a pullback recording.
A pullback pressure recording in the epicardial coronary
artery reflects the conductance of the entire artery as well as
of every individual segment. A pullback recording during
adenosine infusion has the potential to differentiate between
diffusely diseased coronary arteries and a focal problem, such
as a coronary lesion or an underexpanded stent.
Residual Abnormal Pd/Pa and Restenosis
Several mechanisms might influence our findings of in-
creased binary restenosis rate in lesions with a residual
abnormal Pd/Pa distal to the stent. Lesions with a residual
abnormal Pd/Pa might not have been covered completely by
the stent, and our intention to stent from disease-free to
disease-free vessel might not have been achieved. In addition,
a positive remodeling may have made a diffusely diseased
artery look angiographically normal, and a diffusely diseased
vessel might appear smaller because of lack of a normal
reference segment. This might result in underexpansion or
undersizing of the stent. The same degree of in-stent neoin-
timal hyperplasia would contribute to a larger relative lumen
reduction in a smaller stent size compared with a larger stent.
Study Limitations
Several limitations related to the study design should be taken
into account. First, a low FFR and a low Pd/Pa without a focal
step-up during a manual pullback through the artery is a
pathophysiological finding that hypothetically can be applied
to “diffuse disease,” which is an anatomic description. How-
ever, we did not perform intravascular ultrasound imaging to
confirm the presence of diffuse disease. Second, intravascular
ultrasound imaging was not performed to confirm optimal
stent expansion. Third, only disease distal to the stent was
taken into account as a proximal and/or a distal “diffuse
disease segment.” Multiple segments within a patient should
have been taken into account in the statistical analysis, and
this could raise the question of whether either the distal or the
proximal segment would be the strongest predictor, but the
study was not powered for this determination. Fourth, the
regression analyses for restenosis are based on 88 patients
having 25 events only, as evidenced by the very wide
confidence limits. In addition, we performed statistical tests
with no accounting for multiple testing.
All patients were treated with bare-metal stents, and the
overall angiographic restenosis rate was 25.7%, which is
comparable to results with the placebo group in drug-eluting
stent trials.21,22 The use of drug-eluting stents has reduced
restenosis rates dramatically, and our results cannot be
extended to patients treated with drug-eluting stents.
Conclusion
A pullback recording during maximal hyperemia of a coro-
nary artery treated with a stent is a rapid and simple method
to analyze residual hyperemic gradients after coronary stent-
ing. By this technique, it is possible to differentiate between
a persistent gradient caused by incomplete stent deployment
or by diffuse disease proximal or distal to the stent. Further-
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CLINICAL PERSPECTIVE
Fractional flow reserve predicts cardiac events after coronary stent implantation. We assessed the 9-month angiographic
in-stent restenosis rate in the setting of optimal stenting and a persisting gradient distal to the stent as assessed by a pressure
wire pullback recording in the entire length of the artery. In 98 patients, 1 de novo coronary lesion was treated with a
bare-metal stent. After stent implantation, pressure wire measurements (Pdmean hyperemic coronary pressure and
Pamean aortic pressure) were performed in the target vessel: (1) Pd/Pa as distal to the artery as possible and (2) Pd/Pa just
distal to the stent. Residual abnormal Pd/Pa was defined as a pressure drop between Pd/Pa measured at the 2 points.
Fractional flow reserve distal to the artery after stenting was significantly lower (0.880.21 versus 0.970.05; P0.001),
and angiographic in-stent binary restenosis rate was significantly higher (44.0% versus 8.1%; P0.001) in vessels with a
residual abnormal Pd/Pa. Residual abnormal Pd/Pa (odds ratio, 4.39; 95% confidence interval, 1.10 to 18.16; P0.034),
reference vessel size (odds ratio, 0.17; 95% confidence interval, 0.04 to 0.69; P0.013), and stent length (odds ratio, 1.11;
95% confidence interval, 1.03 to 1.21; P0.009) were predictors of angiographic in-stent restenosis after 9 months. The
present study demonstrated that pressure drop from an implanted stent to the distal part of the artery was a predictor of
angiographic in-stent restenosis after 9 months. A pullback recording during maximal hyperemia of a coronary artery
treated with a stent is a rapid and simple method to analyze residual hyperemic gradients after coronary stenting.
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